Jingyao Dai

919 total citations
27 papers, 660 citations indexed

About

Jingyao Dai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jingyao Dai has authored 27 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jingyao Dai's work include Signaling Pathways in Disease (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Jingyao Dai is often cited by papers focused on Signaling Pathways in Disease (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Jingyao Dai collaborates with scholars based in China and United States. Jingyao Dai's co-authors include Zhi‐Nan Chen, Jian‐Li Jiang, Kerry L. Burnstein, Juan Tang, Ping Zhu, Li Wang, Junfeng Jia, Pu Zhao, Conghua Wang and Jian Gu and has published in prestigious journals such as JAMA, PLoS ONE and Scientific Reports.

In The Last Decade

Jingyao Dai

27 papers receiving 657 citations

Peers

Countries citing papers authored by Jingyao Dai

Since Specialization

Citations

This map shows the geographic impact of Jingyao Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyao Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyao Dai more than expected).

Fields of papers citing papers by Jingyao Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyao Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyao Dai. The network helps show where Jingyao Dai may publish in the future.

Co-authorship network of co-authors of Jingyao Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyao Dai. A scholar is included among the top collaborators of Jingyao Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyao Dai. Jingyao Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gold Nanoparticles Carrying Mannose-Binding Lectin and Inflammatory Cytokine Antibodies Improve Sepsis Survival by Modulating Immunity and Reducing Pathogens 2025 ·ACS Applied Materials & Interfaces ·Jian Mao, Yujie Yan, (unknown), (unknown), (unknown), (unknown), Kunwei Niu, (unknown), (unknown), Fan Jiang, Wenjuan Zhang, Kaishan Tao, Jingyao Dai	3
2	A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity 2024 ·ACS Applied Materials & Interfaces ·(unknown), Lei Zheng, Yujie Yan, Miao Wang, Xiaojing Liu, Jingyao Dai	2
3	High‐Throughput Electromechanical Coupling Chip Systems for Real‐Time 3D Invasion/Migration Assay of Cells 2023 ·Advanced Science ·Nan Jiang, (unknown), Yiming Han, Shuyi Wang, (unknown), Jingyao Dai, (unknown), Xiaozhi Liu, Zhiqiang Liu, Jianyong Huang	6
4	Bibliometric analysis of the global research trends and hotspots in chordoma from 2000 to 2020 2022 ·PLoS ONE ·Cuicui Chang, (unknown), Yifan Gao, Jingyao Dai, (unknown)	4
5	Wogonin alleviates liver injury in sepsis through Nrf2‐mediated NF‐κB signalling suppression 2021 ·Journal of Cellular and Molecular Medicine ·(unknown), (unknown), Weinan Guo, (unknown), Kunwei Niu, (unknown), Chengli Liu, Xiangmin Yang, Kaishan Tao, Zhi‐Nan Chen, Jingyao Dai	60
6	[Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. 2018 ·PubMed ·(unknown), Kunwei Niu, Bo Wang, Yijie Li, Congcong Xia, Kaishan Tao, Jingyao Dai	3
7	Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma 2018 ·Cancer Medicine ·(unknown), (unknown), Qichao Huang, Kunwei Niu, Bo Wang, Yijie Li, Chen Dai, Zhi‐Nan Chen, Kaishan Tao, Jingyao Dai	34
8	Polymorphisms in Genes of the De Novo Lipogenesis Pathway and Overall Survival of Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization 2015 ·Asian Pacific Journal of Cancer Prevention ·Yousheng Wu, Dengke Bao, Jingyao Dai, Cheng Chen, Hongxin Zhang, Yefa Yang, Jinliang Xing, Xiao‐Jun Huang, Shaogui Wan	11
9	Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer 2015 ·World Journal of Surgical Oncology ·Shuang Xie, Feng Zhou, Jiaojiao Wang, Haiyan Cao, Yibing Chen, Xiaonan Liu, Zhaohui Zhang, Jingyao Dai, Xianli He	14
10	Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients 2014 ·Medical Oncology ·Huiqing Zhang, Xu Guo, Jingyao Dai, Yousheng Wu, Naijian Ge, Yefa Yang, Jiansong Ji, Hongxin Zhang	11
11	Genetic variations in base excision repair pathway and risk of bladder cancer: A case–control study in the United States 2013 ·Molecular Carcinogenesis ·Hui Xie, Yilei Gong, Jingyao Dai, Xifeng Wu, Jian Gu	15
12	GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes 2012 ·Carcinogenesis ·Jingyao Dai, Jian Gu, Maosheng Huang, Cathy Eng, Scott Kopetz, Lee M. Ellis, Ernest T. Hawk, Xifeng Wu	37
13	Genetic Polymorphism in a VEGF-Independent Angiogenesis Gene ANGPT1 and Overall Survival of Colorectal Cancer Patients after Surgical Resection 2012 ·PLoS ONE ·Jingyao Dai, Shaogui Wan, Feng Zhou, Ronald E. Myers, Xu Guo, Bingshan Li, Xiaoying Fu, Juan Palazzo, Dou Ke-feng, Hushan Yang, Jinliang Xing	14
14	CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia‐inducible transcription factor 1α–mediated pathway in rheumatoid arthritis 2011 ·Arthritis & Rheumatism ·(unknown), Hui Yao, Lina Chen, Junfeng Jia, Li Wang, Jingyao Dai, Zhaohui Zheng, Zhi‐Nan Chen, Ping Zhu	59
15	'Love Teeth Day' campaign in China and its impact on oral public health - the twentieth anniversary 2010 ·BDJ ·Jingyao Dai, Yanhua Hao, (unknown), Deyu Hu, Yimin Zhao	4
16	Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: Correlation with tumor progression and patients’ prognosis 2010 ·Oral Oncology ·Xinjie Yang, Jingyao Dai, Tao Li, Pu Zhang, Qin Ma, Yuan Li, Jun Zhou, Delin Lei	34
17	Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes 2010 ·Journal of Cellular and Molecular Medicine ·Conghua Wang, Jingyao Dai, Li Wang, Junfeng Jia, Zhaohui Zheng, Jin Ding, Zhi‐Nan Chen, Ping Zhu	65
18	Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147 2009 ·Cancer Science ·Pu Zhao, Wei Zhang, Juan Tang, (unknown), Jingyao Dai, Yong Li, Jian‐Li Jiang, Sihe Zhang, Zhi‐Nan Chen	72
19	Silencing of calpain expression reduces the metastatic potential of human osteosarcoma cells 2009 ·Cell Biology International ·Daiming Fan, Jingyao Dai, Juan Tang, Mingmei Wu, (unknown), Jian‐Li Jiang, Qingyu Fan	19
20	Androgen and glucocorticoid regulation of androgen receptor cDNA expression 1995 ·Molecular and Cellular Endocrinology ·Kerry L. Burnstein, (unknown), Jingyao Dai, (unknown)	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact